CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2020		98,035,829
Beginning balance at Dec. 31, 2020	$ 25,289,114	$ 98,036	$ 161,541,448	$ (136,350,370)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,600,649)			(7,600,649)
Unrealized gain (loss) on debt securities	53,737				53,737
Stock-based compensation	2,179,254		2,179,254
Proceeds from exercise of options	1,569		1,569
Stock issued for vested restricted stock awards (in shares)		1,696,467
Stock issued for vested restricted stock awards	0	$ 1,696	(1,696)
Sale of common stock, net of issuance cost (in shares)		19,015,151
Sale of common stock, net of issuance cost	13,137,500	$ 19,016	13,118,484
Shares withheld for taxes on vested restricted stock	(272,049)		(272,049)
Stock warrants issued for referral agreement	$ 19,519		19,519
Ending balance (in shares) at Dec. 31, 2021	118,747,447	118,747,447
Ending balance at Dec. 31, 2021	$ 32,807,995	$ 118,748	176,586,529	(143,951,019)	53,737
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,106,539)			(13,106,539)
Unrealized gain (loss) on debt securities	(138,605)				(138,605)
Stock-based compensation	2,350,314		2,350,314
Stock issued for vested restricted stock awards (in shares)		1,389,677
Stock issued for vested restricted stock awards	0	$ 1,390	(1,390)
Shares withheld for taxes on vested restricted stock	(196,892)		(196,892)
Stock warrants issued for referral agreement	$ 33,043		33,043
Ending balance (in shares) at Dec. 31, 2022	118,747,447	120,137,124
Ending balance at Dec. 31, 2022	$ 21,749,316	$ 120,138	$ 178,771,604	$ (157,057,558)	$ (84,868)